Literature DB >> 20014132

Severe cleidocranial dysplasia and hypophosphatasia in a child with microdeletion of the C-terminal region of RUNX2.

Areeg H El-Gharbawy1, Joseph N Peeden, Ralph S Lachman, John M Graham, Stephen R Moore, David L Rimoin.   

Abstract

Cleidocranial dysplasia (CCD) is a rare autosomal dominant skeletal dysplasia due to mutations causing haploinsufficiency of RUNX2, an osteoblast transcription factor specific for bone and cartilage. The classic form of CCD is characterized by delayed closure of the fontanels, hypoplastic or aplastic clavicles and dental anomalies. Clinical reports suggest that a subset of patients with CCD have skeletal changes which mimic hypophosphatasia (HPP). Mutations in RUNX2 are detected in approximately 65% of cases of CCD, and microdeletions occur in 13%. We present clinical and radiological features in a 6-year-old child with severe CCD manifested by absence of the clavicles marked calvarial hypomineralization, osteoporosis and progressive kyphoscoliosis. HPP features included Bowdler spurs, severe osteopenia, and low alkaline phosphatase. Following negative mutation analysis of RUNX2, comparative genomic hybridization (CGH) microarray was performed. The result revealed a microdeletion in RUNX2, disrupting the C-terminal part of the gene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20014132      PMCID: PMC2799546          DOI: 10.1002/ajmg.a.33146

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription.

Authors:  Faiza Afzal; Jitesh Pratap; Kosei Ito; Yoshiaki Ito; Janet L Stein; Andre J van Wijnen; Gary S Stein; Jane B Lian; Amjad Javed
Journal:  J Cell Physiol       Date:  2005-07       Impact factor: 6.384

2.  Cleidocranial dysplasia plus vascular anomalies with 6p21.2 microdeletion spanning RUNX2 and VEGF.

Authors:  Kosuke Izumi; Naohisa Yahagi; Yasushi Fujii; Masataka Higuchi; Rika Kosaki; Yoko Naito; Gen Nishimura; Noboru Hosokai; Takao Takahashi; Kenjiro Kosaki
Journal:  Am J Med Genet A       Date:  2006-02-15       Impact factor: 2.802

3.  Perinatal lethal hypophosphatasia; clinical, radiologic and morphologic findings.

Authors:  M Shohat; D L Rimoin; H E Gruber; R S Lachman
Journal:  Pediatr Radiol       Date:  1991

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Dysregulation of chondrogenesis in human cleidocranial dysplasia.

Authors:  Qiping Zheng; Eiman Sebald; Guang Zhou; Yuqing Chen; William Wilcox; Brendan Lee; Deborah Krakow
Journal:  Am J Hum Genet       Date:  2005-06-10       Impact factor: 11.025

6.  Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia.

Authors:  Eva Morava; Judit Kárteszi; János Weisenbach; Almuth Caliebe; Stefan Mundlos; Károly Méhes
Journal:  Eur J Pediatr       Date:  2002-10-09       Impact factor: 3.183

7.  Mouse clavicular development: analysis of wild-type and cleidocranial dysplasia mutant mice.

Authors:  L F Huang; N Fukai; P B Selby; B R Olsen; S Mundlos
Journal:  Dev Dyn       Date:  1997-09       Impact factor: 3.780

8.  Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia.

Authors:  I Quack; B Vonderstrass; M Stock; A S Aylsworth; A Becker; L Brueton; P J Lee; F Majewski; J B Mulliken; M Suri; M Zenker; S Mundlos; F Otto
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

9.  Neonatal lethal osteochondrodysplasia with low serum levels of alkaline phosphatase and osteocalcin.

Authors:  Myra H Wyckoff; Chirine El-Turk; Abbot Laptook; Charles Timmons; Francis H Gannon; Xiafang Zhang; Steven Mumm; Michael P Whyte
Journal:  J Clin Endocrinol Metab       Date:  2004-11-23       Impact factor: 5.958

10.  Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia.

Authors:  Ming Ta Michael Lee; Anne Chun-Hui Tsai; Ching-Heng Chou; Feng-Mei Sun; Li-Chen Huang; Pauline Yen; Chyi-Chyang Lin; Chih-Yang Liu; Jer-Yuarn Wu; Yuan-Tsong Chen; Fuu-Jen Tsai
Journal:  Genomic Med       Date:  2008-08-12
View more
  12 in total

1.  Surgical Management and Evaluation of the Craniofacial Growth and Morphology in Cleidocranial Dysplasia.

Authors:  Stephen L Greene; Chung How Kau; Somsak Sittitavornwong; Kathlyn Powell; Noel K Childers; Mary MacDougall; Ejvis Lamani
Journal:  J Craniofac Surg       Date:  2018-06       Impact factor: 1.046

Review 2.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

3.  Classical cleidocranial dysplasia in an adult, due to a novel frameshift pathogenic variant in RUNX2.

Authors:  Malavika Hebbar; Katta M Girisha; Anju Shukla
Journal:  BMJ Case Rep       Date:  2016-05-13

4.  The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice.

Authors:  Matthew B Greenblatt; Jae-Hyuck Shim; Weiguo Zou; Despina Sitara; Michelle Schweitzer; Dorothy Hu; Sutada Lotinun; Yasuyo Sano; Roland Baron; Jin Mo Park; Simon Arthur; Min Xie; Michael D Schneider; Bo Zhai; Steven Gygi; Roger Davis; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2010-06-14       Impact factor: 14.808

Review 5.  Molecular genetics of supernumerary tooth formation.

Authors:  Xiu-Ping Wang; Jiabing Fan
Journal:  Genesis       Date:  2011-04-01       Impact factor: 2.487

Review 6.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 7.  Delayed Eruption of Permanent Dentition and Maxillary Contraction in Patients with Cleidocranial Dysplasia: Review and Report of a Family.

Authors:  A Impellizzeri; G Midulla; U Romeo; C La Monaca; E Barbato; G Galluccio
Journal:  Int J Dent       Date:  2018-07-04

8.  Cleidocranial dysplasia syndrome with epilepsy: a case report.

Authors:  Yimei Ma; Fumin Zhao; Dan Yu
Journal:  BMC Pediatr       Date:  2019-04-08       Impact factor: 2.125

Review 9.  Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives.

Authors:  Amaka C Offiah; Jerry Vockley; Craig F Munns; Jun Murotsuki
Journal:  Pediatr Radiol       Date:  2018-10-03

10.  Genetic Pattern, Orthodontic and Surgical Management of Multiple Supplementary Impacted Teeth in a Rare, Cleidocranial Dysplasia Patient: A Case Report.

Authors:  Alessio Danilo Inchingolo; Assunta Patano; Giovanni Coloccia; Sabino Ceci; Angelo Michele Inchingolo; Grazia Marinelli; Giuseppina Malcangi; Valentina Montenegro; Claudia Laudadio; Giulia Palmieri; Ioana Roxana Bordea; Emanuela Ponzi; Paola Orsini; Romina Ficarella; Antonio Scarano; Felice Lorusso; Gianna Dipalma; Massimo Corsalini; Mattia Gentile; Daniela Di Venere; Francesco Inchingolo
Journal:  Medicina (Kaunas)       Date:  2021-12-10       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.